Biovie Stock Price, News & Analysis
Company Description
Biovie (NASDAQ: BIVIW) is a publicly traded company in the Pharmaceutical Preparations sector.
BIVIW stock has declined 5.7% over the past year. Shares last traded at $0.3300.
On a trailing twelve-month basis, Biovie reported net income of -$17.5M and diluted earnings per share of $-12.12.
This page provides a comprehensive overview of BIVIW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Biovie (BIVIW) stock last traded at $0.3300. Over the past 12 months, the stock has lost 5.7%.
Latest News
SEC Filings
Biovie has filed 1 recent SEC filing, including 1 Form SCHEDULE 13D. The most recent filing was submitted on March 25, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BIVIW SEC filings →
Financial Highlights
operating income reached -$18.1M, and net income was -$17.5M. Diluted earnings per share stood at $-12.12. The company generated -$19.0M in operating cash flow. With a current ratio of 9.10, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Biovie (BIVIW) currently stands at 494 shares, up 366.0% from the previous reporting period, representing 0.1% of the float. Over the past 12 months, short interest has decreased by 62.6%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Biovie (BIVIW) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
BIVIW Company Profile & Sector Positioning
Biovie (BIVIW) operates in the Pharmaceutical Preparations sector and is listed on the NASDAQ.